Mink therapeutics announces confidential submission of draft registration statement for proposed initial public offering

New york, july 28, 2021 (globe newswire) -- mink therapeutics today announced that it has confidentially submitted a draft registration statement on form s-1 with the securities and exchange commission (the "sec") relating to the proposed initial public offering of its common stock. the number of shares to be offered and the price range for the proposed offering have not yet been determined. the initial public offering is expected to take place after the sec completes its review process, subject to market and other conditions. mink is a subsidiary of agenus inc. (nasdaq: agen).
AGEN Ratings Summary
AGEN Quant Ranking